Cefixime NEW
| Price | $45 | $65 | $94 |
| Package | 25mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2025-04-30 |
Product Details
| Product Name: Cefixime | CAS No.: 79350-37-1 |
| Purity: 99.33% | Supply Ability: 10g |
| Release date: 2025/04/30 |
Product Introduction
Bioactivity
| Name | Cefixime |
| Description | Cefixime (FR-17027) is a broad-spectrum, third-generation cephalosporin antibiotic derived semisynthetically from the marine fungus Cephalosporium acremonium with antibacterial activity. As does penicillin, the beta-lactam antibiotic cefixime inhibits bacterial cell wall synthesis by disrupting peptidoglycan synthesis, resulting in a reduction in bacterial cell wall stability and bacterial cell lysis. Stable in the presence of a variety of beta-lactamases, this agent is more active against gram-negative bacteria and less active against gram-positive bacteria compared to second-generation cephalosporins. |
| Cell Research | The morphological changes of serovar Typhimurium FP39 in THP-1 cells are studied by light microscopy and transmission electron microscopy. Infected THP-1 cells are treated for 4 h with 0.5 μg of cefixime/ml. (Only for Reference) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | Ethanol : hardly dissolve H2O : Insoluble DMSO : 50 mg/mL (110.27 mM), Sonication is recommended. |
| Keywords | PBPs | Inhibitor | inhibit | FR17027 | FR 17027 | FK027 | FK 027 | CL284635 | CL 284635 | Cefixime | Bacterial | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Dehydroacetic acid sodium | Ampicillin sodium | Methyl anthranilate | Doxycycline (hyclate) | Kanamycin sulfate | Urethane | Sulfamethoxazole sodium | Doxycycline | EDTA copper(II) disodium salt | Isoeugenol | Dimethyl sulfoxide |
| Related Compound Libraries | Bioactive Compound Library | Approved Drug Library | Pediatric Drug Library | Antibiotics Library | Drug Repurposing Compound Library | Beta-Lactam Compound Library | Inhibitor Library | NO PAINS Compound Library | FDA-Approved Drug Library | Clinical Compound Library | Bioactive Compounds Library Max | Human Metabolite Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $45.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $45.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-08 | ||
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2025-04-29 | ||
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-22 | ||
| $150.00 |
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-12-05 | ||
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-21 | ||
| $100.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2024-08-13 | |
|
VIP5Y
|
Sinoway Industrial co., ltd.
|
2024-05-27 | ||
| $15.00 |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-22 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY